Intelligence · Clinical Pipeline
Phase III Pipeline Programs
Late-stage pivotal and registrational clinical programs nearing regulatory submission.
- Programs
- 5,427
Quick answer
NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.
Top sponsors
- Takeda 393 programs
- United Therapeutics Europe 199 programs
- Anaxis Pharma 198 programs
- Chinese Academy of 189 programs
- Teva Pharma 148 programs
- Novartis India 145 programs
- BRIGHT MINDS BIOSCIENCES 139 programs
- PARItec 139 programs
- HOFFMANN-LA ROCHE 134 programs
- Regeneron UK 129 programs
- AstraZeneca 120 programs
- First People's Hospital 117 programs
-
acyclovir
Ultragenyx UK Limited
Herpes Simplex
2 trials -
adalimumab
AbbVie
Pyoderma Gangrenosum
1 trial -
administering RASI (the trade name or universal name will not be stipulated) before stenting
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Carotid Stenosis
1 trial -
adoptive immunotherapy
Chinese PLA General Hospital
Hepatocellular Carcinoma
1 trial -
aflibercept
Regeneron UK Limited
Retinopathy of Prematurity
1 trial -
aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®)
Regeneron UK Limited
Ovarian Neoplasms
2 trials -
aflibercept 8 mg PFS
Regeneron UK Limited
Diabetic Macular Edema (DME)
1 trial -
afuzosin
Sanofi Pasteur
Benign Prostatic Hyperplasia
1 trial -
agalsidase alfa
Takeda
Fabry Disease
3 trials -
albiglutide + insulin glargine
GlaxoSmithKline
Diabetes Mellitus, Type 2
1 trial -
albuterol (Armstrong Albuterol HFA)
Amphastar France Pharmaceuticals
Asthma
1 trial -
albuterol HFA (Armstrong's)
Amphastar France Pharmaceuticals
Asthma
1 trial -
albuterol aerosol by HFA MDI
Teva Pharma GmbH
Exercise-induced Bronchospasm
1 trial -
alirocumab SAR236553 (REGN727)
Regeneron UK Limited
Hypercholesterolemia
8 trials -
alirocumab SAR236553 (REGN727)
Regeneron UK Limited
Hypercholesterolaemia
2 trials -
alosetron
GlaxoSmithKline
Irritable Colon
1 trial -
alpha1-proteinase inhibitor
Takeda
Covid19
1 trial -
alprazolam, Placebo matching Staccato® alprazolam and without active substance
Lacuna Pharma Pty Ltd
Treatment of stereotypical prolonged seizure
1 trial -
amifampridine phosphate
CATALYST PHARMACEUTICALS, INC.
Myasthenic Syndromes, Congenital
1 trial -
ampreloxetine
Theravance Biopharma Ireland Umited
Symptomatic Neurogenic Orthostatic Hypotension
4 trials -
apomorphine infusion
SUPERNUS PHARMACEUTICALS, INC.
Idiopathic Parkinson's Disease
1 trial -
asparaginase
Children's Hospital of Fudan University
Leukemia
2 trials -
asparaginase
United Therapeutics Europe Ltd
Lymphoma
1 trial -
avapritinib
Blueprint Medicines (Netherlands) B.V.
GIST
1 trial -
avatrombopag
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Thrombocytopenia
1 trial -
avoralstat
Biocryst
Hereditary Angioedema
1 trial -
azithromycin SR (Zithromax; compound: CP-62,993)
Pfizer
Bronchitis, Chronic
1 trial -
azithromycin sustained release
Pfizer
Pneumonia
1 trial -
bLF (Bovine lactoferrin)
United Therapeutics Europe Ltd
Neonatal Sepsis
1 trial -
balcinrenone/dapagliflozin 15 mg/10 mg and matching placebo for dapagliflozin 10 mg
AstraZeneca
Heart Failure and Impaired Kidney Function
1 trial -
bamlanivimab 7000mg
SAB Biotherapeutics
Coronavirus
1 trial -
bapineuzumab
Pfizer
Alzheimer Disease
1 trial -
batch 1 of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) (MCV4)
CanSino Biologics
Meningococcal Meningitis
1 trial -
beclomethasone dipropionate (QVAR)
Teva Pharma GmbH
Asthma
1 trial -
behavior intervention and male circumcision
Xiyuan Hospital of China Academy of Chinese Medical Sciences
HIV
1 trial -
belapectin
GALECTIN THERAPEUTICS INC
Prevention of Esophageal Varices
1 trial -
bempedoic acid
Esperion Therapeutics
Hypercholesterolemia
5 trials -
bempegaldesleukin
Nektar Therapeutics UK Limited
Renal Cell Carcinoma
1 trial -
bendamustine
Teva Pharma GmbH
Non-Hodgkin's Lymphoma
2 trials -
berotralstat
Biocryst
Hereditary Angioedema
2 trials -
betamethasone
Ultragenyx UK Limited
Respiratory Distress Syndrome
1 trial -
bevacizumab
Outlook Therapeutics NL B. V.
Neovascular Age-related Macular Degeneration
1 trial -
bevacizumab
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Disease Free Survival
1 trial -
bevacizumab
Outlook Therapeutics NL B. V.
Age-related Macular Degeneration
4 trials -
bexarotene
Eisai Co.,
Non-small Cell Lung Cancer
1 trial -
bicyclol, 25mg/ tablet
BRIGHT MINDS BIOSCIENCES INC.
Drug-Induced Acute Liver Injury
1 trial -
bimatoprost ophthalmic solution formulation A
Allergan Pharmaceuticals International Limited
Glaucoma
1 trial -
bimekizumab
Lacuna Pharma Pty Ltd
Hidradenitis Suppurativa
1 trial
Frequently asked questions
How many Phase III pipeline programs are in the directory?
5,427 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.
Data attribution: Data sources · All pipeline programs